Past CureTalks
New Findings in Gastrointestinal Cancers
Gastrointestinal (GI) cancers are the second leading cause of cancer deaths worldwide amounting to 4.5 million global deaths per year. According to the American Cancer Society statistics, GI cancers collectively have the highest incidence and account for 20% of estimated…
Managing your Mental Health During COVID-19
Is the new practice of social distancing or reducing close physical proximity with others contributing to another deadly epidemic, that of social isolation and loneliness? As the world grapples with COVID-19, the population worldwide is escalating into negative psychological reactions…
COVID 19 pandemic is here. What to expect?
COVID 19 is now a global pandemic.The cases of coronavirus are increasing rapidly across the world with the count crossing 246,005 globally and increasing every day. The virus, which originated from China, has rapidly spread to about 160 countries.This is…
CLR 131 – A New Approach in Multiple Myeloma Treatment
CLR 131 is a targeted small-molecule that is being developed for the treatment of myeloma and lymphoma, as well as pediatric and head & neck cancers by Cellectar Biosciences. It works by delivering a radioactive, toxic compound directly to tumor…
Latest in Brain Tumor Treatments and Trials
Brain tumors can be among the most challenging cancers to treat. The blood-brain barrier, a natural defense mechanism that shields the brain from harm can also prevent cancer treatments from reaching tumors. However, immunotherapy, precision medicine, and the other new…